Anwulignan structure
|
Common Name | Anwulignan | ||
---|---|---|---|---|
CAS Number | 107534-93-0 | Molecular Weight | 328.402 | |
Density | 1.159 | Boiling Point | 467.0±40.0 °C at 760 mmHg | |
Molecular Formula | C20H24O4 | Melting Point | 70-71℃ | |
MSDS | Chinese USA | Flash Point | 236℃ |
Use of AnwulignanMacelignan(Anwuligan) is a natural compound isolated from Myristica fragrans Houtt; possesses therapeutic potentials against neurodegenerative diseases with oxidative stress and neuroinflammation.IC50 value:Target: in vitro: Macelignan significantly attenuated the ROS production and neurotoxicity induced by glutamate in HT22 cell [1]. At 24 h of biofilm growth, S. mutans, A. viscosus and S. sanguis biofilms were reduced by up to 30%, 30% and 38%, respectively, after treatment with 10 microg/mL macelignan for 5 min [2]. Cisplatin-induced phosphorylation of c-Jun N-terminal kinase1/2 (JNK1/2) and extracellular signal-regulated kinase1/2 (ERK1/2) was abrogated by pretreatment with macelignan, however, that of p38 was not significantly affected [3].in vivo: Macelignan attenuated the expression of phosphorylated c-Jun in cisplatin-treated mice [3]. Daily administration of macelignan reduced the spatial memory impairments induced by the chronic LPS infusions [4]. |
Name | 4-[(2S,3R)-4-(1,3-benzodioxol-5-yl)-2,3-dimethylbutyl]-2-methoxyphenol |
---|---|
Synonym | More Synonyms |
Description | Macelignan(Anwuligan) is a natural compound isolated from Myristica fragrans Houtt; possesses therapeutic potentials against neurodegenerative diseases with oxidative stress and neuroinflammation.IC50 value:Target: in vitro: Macelignan significantly attenuated the ROS production and neurotoxicity induced by glutamate in HT22 cell [1]. At 24 h of biofilm growth, S. mutans, A. viscosus and S. sanguis biofilms were reduced by up to 30%, 30% and 38%, respectively, after treatment with 10 microg/mL macelignan for 5 min [2]. Cisplatin-induced phosphorylation of c-Jun N-terminal kinase1/2 (JNK1/2) and extracellular signal-regulated kinase1/2 (ERK1/2) was abrogated by pretreatment with macelignan, however, that of p38 was not significantly affected [3].in vivo: Macelignan attenuated the expression of phosphorylated c-Jun in cisplatin-treated mice [3]. Daily administration of macelignan reduced the spatial memory impairments induced by the chronic LPS infusions [4]. |
---|---|
Related Catalog | |
References |
Density | 1.159 |
---|---|
Boiling Point | 467.0±40.0 °C at 760 mmHg |
Melting Point | 70-71℃ |
Molecular Formula | C20H24O4 |
Molecular Weight | 328.402 |
Flash Point | 236℃ |
Exact Mass | 328.167450 |
PSA | 47.92000 |
LogP | 5.22 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.574 |
Storage condition | -20°C |
RIDADR | NONH for all modes of transport |
---|---|
HS Code | 29329990 |
Macelignan attenuates LPS-induced inflammation and reduces LPS-induced spatial learning impairments in rats.
Neurosci. Lett. 448(1) , 110-4, (2008) Previous studies have shown that macelignan has anti-inflammatory and neuroprotective effects. Subsequently, in the current study, we demonstrate that oral administrations of macelignan reduce the hip... |
Phenol, 4-[(2S,3R)-4-(1,3-benzodioxol-5-yl)-2,3-dimethylbutyl]-2-methoxy- |
HMS2219A18 |
(+)-Anwulignan |
Macelignan |
4-[(2S,3R)-4-(1,3-Benzodioxol-5-yl)-2,3-dimethylbutyl]-2-methoxyphenol |
UNII-8PP3614Z43 |
austrobailignan 6 |
Anwuligan |
Macelignan, (+)- |